S&P 500

5.323,05

0,28%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sonoma Pharmaceuticals Inc (SNOA)
Sonoma Pharmaceuticals Inc (SNOA) Notícias

SNOA

Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SNOA

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/03/2024	18:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
08/03/2024	18:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
08/02/2024	18:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
29/12/2023	19:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
21/11/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
03/11/2023	17:30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
30/10/2023	08:30	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
13/10/2023	18:19	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
11/10/2023	17:30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
21/09/2023	10:35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
19/09/2023	17:30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
27/07/2023	17:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
21/07/2023	18:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
21/06/2023	17:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
10/05/2023	08:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
14/02/2023	18:35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
25/01/2023	11:25	AllPennyStocks.com	Premarket Is Shaping Up To Be Wild For This Micro Cap	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
30/12/2022	19:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
23/12/2022	19:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
12/10/2022	18:04	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
29/06/2022	17:03	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
01/06/2022	07:00	Business Wire	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
03/05/2022	07:00	Business Wire	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
30/03/2022	07:00	Business Wire	Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
11/02/2022	18:30	Business Wire	Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
20/01/2022	18:40	Business Wire	Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
13/01/2022	18:02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
05/01/2022	18:55	Business Wire	Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
15/11/2021	10:00	Business Wire	Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc
09/11/2021	09:00	Business Wire	Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia	NASDAQ:SNOA	Sonoma Pharmaceuticals Inc